Post by
Fishercat1 on Jan 12, 2021 8:26am
Exclusive License And Exclusive Rights To Patent $$$$$
Sairiyo has an exclusive license from a research and development organization to develop and commercialize reformulated Cepharanthine for all diseases and exclusive rights to the patent, method of manufacturing, clinical supply, pre-clinical data and know-how to support FDA clinical trials.
Comment by
FreeDom789 on Jan 12, 2021 8:59am
This is good news! Pharmadrug Looking at becoming a Biotech company as well as a pharmaceutical company! If this Loi works out it'll be big for BUZZ! Buzz looking at becoming a big player! GLTA